3 results
8-K
EX-99.1
MDXG
Mimedx Group Inc
7 Dec 21
Regulation FD Disclosure
12:45pm
to maintaining healthy cartilage: Wnt pathway signaling Nuclear Factor Kappa β signaling Transforming Growth Factor β signaling mdHACM is a potential … WNT SIGNALLING mdHACM TREATMENT β-catenin nuclear localization
42 DISEASE MODIFICATION POTENTIAL mdHACM regulates proliferative and hypertrophic
8-K
EX-99.1
MDXG
Mimedx Group Inc
10 Aug 20
Regulation FD Disclosure
9:31am
targeting various nuclear hormone receptors. This work led to eight pharmaceutical partnerships and six marketed medicines, including two SERMs (Fablyn
- Prev
- 1
- Next